Safety and Efficacy of MLC601 in Iranian Patients after Stroke: A Double-Blind, Placebo-Controlled Clinical Trial

Objective. To investigate the safety and efficacy of MLC601 (NeuroAid) as a traditional Chinese medicine on motor recovery after ischemic stroke. Methods. This study was a double-blind, placebo-controlled clinical trial on 150 patients with a recent (less than 3 month) ischemic stroke. All patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Harandi, A. A., Abolfazli, R., Hatemian, A., Ghragozlee, K., Ghaffar-Pour, M., Karimi, M., Shahbegi, S., Pakdaman, H., Tabasi, M., Tabatabae, A. L., Nourian, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138057/
https://www.ncbi.nlm.nih.gov/pubmed/21776364
http://dx.doi.org/10.4061/2011/721613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3138057/
https://www.ncbi.nlm.nih.gov/pubmed/21776364
http://dx.doi.org/10.4061/2011/721613

Ejemplares similares